Package 0121-1019-30

Brand: buprenorphine hydrochloride

Generic: buprenorphine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0121-1019-30
Digits Only 0121101930
Product NDC 0121-1019
Product ID 0121-1019_1ce64f53-ed3c-692a-e063-6394a90a86d2
Description

30 TABLET in 1 BOTTLE (0121-1019-30)

Marketing

Marketing Status
Marketed Since 2023-10-12
Brand buprenorphine hydrochloride
Generic buprenorphine hydrochloride
Sample Package No

Linked Drug Pages (1)

buprenorphine hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "1ce64f53-ed3c-692a-e063-6394a90a86d2", "openfda": {"upc": ["0301212038301", "0301211019301"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["442831cf-9636-433a-9a12-e9a8cd31f72a"], "manufacturer_name": ["PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0121-1019-30)", "package_ndc": "0121-1019-30", "marketing_start_date": "20231012"}], "brand_name": "buprenorphine hydrochloride", "product_id": "0121-1019_1ce64f53-ed3c-692a-e063-6394a90a86d2", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0121-1019", "dea_schedule": "CIII", "generic_name": "buprenorphine hydrochloride", "labeler_name": "PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "buprenorphine hydrochloride", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA090622", "marketing_category": "ANDA", "marketing_start_date": "20231012", "listing_expiration_date": "20261231"}